Published in J Gastrointest Surg on January 28, 1999
Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell (2012) 2.16
Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol (2009) 1.63
Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut (2009) 1.20
A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer (2011) 1.19
Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells. Am J Physiol Gastrointest Liver Physiol (2011) 1.17
Prospective randomized trial comparing Billroth I and Roux-en-Y procedures after distal gastrectomy for gastric carcinoma. World J Surg (2005) 0.99
Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha. Biochem J (2007) 0.94
Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg (2004) 0.93
Barrett esophagus: what a mouse model can teach us about human disease. Cell Cycle (2012) 0.90
Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J Gastroenterol (2005) 0.88
CDX2 hox gene product in a rat model of esophageal cancer. J Exp Clin Cancer Res (2009) 0.88
Esophageal Cancer: Insights From Mouse Models. Cancer Growth Metastasis (2015) 0.88
Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. Exp Biol Med (Maywood) (2014) 0.86
Upper gastrointestinal cancer and reflux disease. J Gastric Cancer (2013) 0.86
Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy. Can J Gastroenterol (2010) 0.85
Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systems. Stem Cell Res Ther (2013) 0.83
Morbidity and mortality results from a prospective randomized controlled trial comparing Billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer. World J Surg (2012) 0.82
Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling. Surg Endosc (2008) 0.82
Successful evaluation of a new animal model using mice for esophageal adenocarcinoma. Langenbecks Arch Surg (2010) 0.82
Do proton pump inhibitors protect against cancer progression in GERD? Surg Today (2012) 0.81
Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol (2009) 0.80
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. PLoS One (2014) 0.80
A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents. Dig Dis Sci (2007) 0.80
Barrett's esophagus and animal models. Ann N Y Acad Sci (2011) 0.79
Double stapling Roux-en-Y reconstruction in a laparoscopy-assisted distal gastrectomy. Surg Today (2010) 0.78
Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway. Cancer (2010) 0.78
Bile acid receptor TGR5, NADPH Oxidase NOX5-S and CREB Mediate Bile Acid-Induced DNA Damage In Barrett's Esophageal Adenocarcinoma Cells. Sci Rep (2016) 0.77
Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence. World J Gastrointest Endosc (2015) 0.75
Inflammation-related carcinogenesis and prevention in esophageal adenocarcinoma using rat duodenoesophageal reflux models. Cancers (Basel) (2011) 0.75
TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett's esophagus: Case series and findings. World J Gastroenterol (2017) 0.75
Columnar Metaplasia in Three Types of Surgical Mouse Models of Esophageal Reflux. Cell Mol Gastroenterol Hepatol (2017) 0.75
Effects of bile acids on cyclooxygenase-2 expression in a rat model of duodenoesophageal anastomosis. World J Gastroenterol (2014) 0.75
High yield reproducible rat model recapitulating human Barrett's carcinogenesis. World J Gastroenterol (2017) 0.75
Long-term comparison of boomerang-shaped jejunal interposition and Billroth-I reconstruction after distal gastrectomy. World J Surg (2015) 0.75
Trypsin activity and bile acid concentrations in the esophagus after distal gastrectomy. Dig Dis Sci (2006) 0.75
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg (1983) 2.91
The polymorphic acetylation of dapsone in man. Clin Pharmacol Ther (1971) 2.81
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc (1995) 2.59
Evaluation of esophageal motor function in clinical practice. Neurogastroenterol Motil (2013) 2.54
Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44
Induction of tumour immunity with tumour cells treated with iodoacetate. Nature (1966) 2.42
A prospective, randomized comparison of laparoscopic appendectomy with open appendectomy. Laparoscopic Appendectomy Study Group. Am J Surg (1995) 2.37
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol (1986) 2.25
The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
STUDIES IN DIABETIC ACIDOSIS AND COMA, WITH PARTICULAR EMPHASIS ON THE RETENTION OF ADMINISTERED POTASSIUM. J Clin Invest (1949) 2.12
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07
Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci (1992) 2.04
Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg (1995) 1.98
Management of esophageal perforation. Am J Surg (1980) 1.90
Current concepts in the management of paraesophageal hiatal hernia. J Clin Gastroenterol (1999) 1.84
The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81
Acute pancreatitis with hyperlipemia. Surgery (1971) 1.79
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75
Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery (1980) 1.74
Polyps and carcinoma of the large bowel in the South African Bantu. Cancer (1970) 1.73
Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg (1982) 1.71
Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg (1979) 1.69
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66
Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg (1992) 1.64
Length of the distal esophageal sphincter and competency of the cardia. Am J Surg (1986) 1.64
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
Isolated cerebral mucormycosis: case report and therapeutic considerations. Neurosurgery (1994) 1.63
Third ventricular cysticercal cyst mimicking a colloid cyst: case report. Neurosurgery (1995) 1.62
En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg (2008) 1.61
Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg (1999) 1.60
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg (2000) 1.59
Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg (1997) 1.58
Weight gain during the first year of life in relation to maternal smoking and breast feeding in Norway. J Epidemiol Community Health (1997) 1.55
Cystic and bullous lung disease. Ann Thorac Surg (1991) 1.55
Indications, benefits and outcome of laparoscopic Nissen fundoplication. Dig Dis (1997) 1.54
CT of focal hepatic injury due to surgical retractor. AJR Am J Roentgenol (1996) 1.54
Immunosuppression in patients with Barrett's esophagus. Surgery (1992) 1.54
Potentially curable cancer of the esophagus. Cancer (1982) 1.53
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg (2000) 1.53
The evaluation of objective measurements of gastroesophageal reflux and their contribution to patient management. Surg Clin North Am (1976) 1.52
Malformations associated with congenital absence of the gall bladder. J Med Genet (1983) 1.50
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg (1992) 1.50
Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis (1996) 1.49